Naturhouse Health (ES:NTH)
BME:NTH
NTH Stock Chart & Stats
€2.30
€0.03(1.46%)
At close: 4:00 PM EST
€2.30
€0.03(1.46%)
Day’s Range― - ―
52-Week Range€1.65 - €2.82
Previous CloseN/A
Volume12.72K
Average Volume (3M)24.74K
Market Cap
€155.27M
Enterprise Value€135.61M
Total Cash (Recent Filing)€23.34M
Total Debt (Recent Filing)€2.72M
Price to Earnings (P/E)9.4
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield11.15%
Share Statistics
EPS (TTM)0.16
Shares Outstanding60,000,000
10 Day Avg. Volume17,416
30 Day Avg. Volume24,740
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)4.53
Price to Sales (P/S)8.87
P/FCF Ratio32.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.15
Revenue Forecast (FY)€48.10M
Bulls Say, Bears Say
Bulls Say
High Profitability And MarginsConsistently high EBIT and net margins demonstrate that Naturhouse converts revenue into durable earnings efficiently. Strong margins provide a structural earnings buffer against top-line softness, enable internal funding for dividends or investment, and help sustain cash flows during cyclical or competitive pressure.
Solid Cash Generation And ConversionFree cash flow resilience—even rising in 2025 despite a revenue drop—signals disciplined working-capital and operational management. Reliable cash conversion supports sustainable shareholder returns, funds reinvestment or franchise support without heavy new borrowing, and underpins long-term financial flexibility.
Conservative Leverage And Strong ROELow historical leverage and high ROE imply efficient capital use and capacity to absorb shocks without refinancing stress. This structural balance-sheet strength gives the company room to support franchisees, sustain dividends, or invest selectively while maintaining financial resilience through downturns.
Bears Say
Steep Multi-year Revenue DeclineA persistent top-line contraction culminating in -37.9% in 2025 undermines long-term earnings durability. Even with strong margins, shrinking revenue reduces scale economics in centers and product sales, constrains growth options, and raises the risk that profits and cash flow will be harder to sustain over time.
Material Balance-sheet Erosion In 2025A sharp decline in equity and assets materially shrinks the company's buffer against operational or market shocks. Lower net worth reduces capacity to lend support to franchisees, fund growth or absorb further revenue weakness without either cutting returns or taking on incremental leverage.
Concentration On In-center Product Sales And FranchisingRevenue concentration on repeat in-center product purchases and franchised centers creates structural exposure to foot-traffic, consumer behavior shifts, and franchise network health. If consumer preferences move away from in-person consultations, the core recurring revenue stream could be structurally impaired over months to years.
Naturhouse Health News
NTH FAQ
What was Naturhouse Health’s price range in the past 12 months?
Naturhouse Health lowest stock price was €1.65 and its highest was €2.82 in the past 12 months.
What is Naturhouse Health’s market cap?
Naturhouse Health’s market cap is €155.27M.
When is Naturhouse Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Naturhouse Health’s earnings last quarter?
Naturhouse Health released its earnings results on Feb 26, 2024. The company reported €0.065 earnings per share for the quarter, beating the consensus estimate of N/A by €0.065.
Is Naturhouse Health overvalued?
According to Wall Street analysts Naturhouse Health’s price is currently Overvalued.
Does Naturhouse Health pay dividends?
Naturhouse Health pays a Quarterly dividend of €0.081 which represents an annual dividend yield of 11.15%. See more information on Naturhouse Health dividends here
What is Naturhouse Health’s EPS estimate?
Naturhouse Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Naturhouse Health have?
Naturhouse Health has 60,000,000 shares outstanding.
What happened to Naturhouse Health’s price movement after its last earnings report?
Naturhouse Health reported an EPS of €0.065 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.459%.
Which hedge fund is a major shareholder of Naturhouse Health?
Currently, no hedge funds are holding shares in ES:NTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Naturhouse Health
Naturhouse Health (NTH) is a global leader in the health and wellness sector, specializing in nutritional counseling and weight management solutions. The company operates through a franchise model, providing its clients with personalized dietary plans, supplements, and a range of health-related products. NTH focuses on promoting healthy lifestyles through its innovative programs that cater to individual needs, making it a trusted partner in achieving weight loss and overall well-being.
Technical Analysis
DISTRIBUIDORA INTERNACIONAL DE ALIMENTACION
―
EBRO FOODS
―
Pescanova
―
DEOLEO S.A.
―
Puig Brands, S.A.
―
Options Prices
Currently, No data available
---